Clinical Trial: Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959563) titled 'Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV' on April 28.

Brief Summary: Conducting an early phase clinical trial to assess HPV Antigen Presentation Therapeutic Biological Product Mix activity that suggests the potential for clinical benefit of HPV patients.

1. Treat Infection of Multiple HPV Virus Strains via Trained Immunity.

2. Activate human HPV Antigen Presentation Reaction.

3. The human antigen presenting cells (APCs) can treat the HPV virus protein antigens into small peptide fragments, and then clear HPV virus in vivo.

Study Start Date: April 28

Study Type: INTERVENTIONAL

Conditio...